Valion Bio, Inc. (VBIO) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $16.80M | +562.6% |
| 2024 | $2.54M | -29.2% |
| 2023 | $3.58M | -1.4% |
| 2022 | $3.63M | -72.6% |
| 2021 | $13.27M | +1227.6% |
| 2020 | -$1.18M | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $16.80M | +562.6% |
| 2024 | $2.54M | -29.2% |
| 2023 | $3.58M | -1.4% |
| 2022 | $3.63M | -72.6% |
| 2021 | $13.27M | +1227.6% |
| 2020 | -$1.18M | — |